Diagnostic Accuracy of a Novel Stool Antigen Test for Helicobacter pylori Infection in a Medical Checkup Setting : A Prospective Cohort Study
Objective Of the highly accurate tests for current Helicobacter pylori infection, the urea breath test (UBT) and stool antigen test (SAT) are noninvasive and do not require endoscopy. We conducted a prospective study to evaluate the accuracy of the newly developed SAT in a medical checkup setting. Methods The accuracy of the proposed SAT was examined by determining H. pylori infection status based on a history of eradication therapy, endoscopic H. pylori infection diagnosis, and blood tests (serum H. pylori antibody, serum PG II) in individuals undergoing esophagogastroduodenoscopy (EGD) during a health checkup. Results The new SAT showed 97.3% (108/111) sensitivity for those "currently infected," as well as 99.3% (530/534), 98.0% (402/410), and 98.7% (932/944) specificity for those "never infected," those "previously infected," and those "never/previously infected", respectively. Conclusion The newly developed H. pylori SAT may be useful for diagnosing H. pylori infection. Patients should be suspected of being infected even after H. pylori eradication if they have a high cutoff index in this test.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
---|---|
Enthalten in: |
Internal medicine (Tokyo, Japan) - (2023) vom: 06. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kubo, Kimitoshi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Helicobacter pylori |
---|
Anmerkungen: |
Date Revised 05.11.2023 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.2169/internalmedicine.2412-23 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364183926 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM364183926 | ||
003 | DE-627 | ||
005 | 20231226094913.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2169/internalmedicine.2412-23 |2 doi | |
028 | 5 | 2 | |a pubmed24n1213.xml |
035 | |a (DE-627)NLM364183926 | ||
035 | |a (NLM)37926549 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kubo, Kimitoshi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Diagnostic Accuracy of a Novel Stool Antigen Test for Helicobacter pylori Infection in a Medical Checkup Setting |b A Prospective Cohort Study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 05.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Objective Of the highly accurate tests for current Helicobacter pylori infection, the urea breath test (UBT) and stool antigen test (SAT) are noninvasive and do not require endoscopy. We conducted a prospective study to evaluate the accuracy of the newly developed SAT in a medical checkup setting. Methods The accuracy of the proposed SAT was examined by determining H. pylori infection status based on a history of eradication therapy, endoscopic H. pylori infection diagnosis, and blood tests (serum H. pylori antibody, serum PG II) in individuals undergoing esophagogastroduodenoscopy (EGD) during a health checkup. Results The new SAT showed 97.3% (108/111) sensitivity for those "currently infected," as well as 99.3% (530/534), 98.0% (402/410), and 98.7% (932/944) specificity for those "never infected," those "previously infected," and those "never/previously infected", respectively. Conclusion The newly developed H. pylori SAT may be useful for diagnosing H. pylori infection. Patients should be suspected of being infected even after H. pylori eradication if they have a high cutoff index in this test | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Helicobacter pylori | |
650 | 4 | |a infection status | |
650 | 4 | |a stool antigen test diagnostic accuracy | |
700 | 1 | |a Mabe, Katsuhiro |e verfasserin |4 aut | |
700 | 1 | |a Kikuchi, Shogo |e verfasserin |4 aut | |
700 | 1 | |a Kato, Mototsugu |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Internal medicine (Tokyo, Japan) |d 1996 |g (2023) vom: 06. Nov. |w (DE-627)NLM012606731 |x 1349-7235 |7 nnns |
773 | 1 | 8 | |g year:2023 |g day:06 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.2169/internalmedicine.2412-23 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2023 |b 06 |c 11 |